Studies performed by Davis et al. and Bowerman et al. have addressed the issue of insulin sensitivity among patients with different types of SMA, suggesting that the interactions involved are far more complex than the mechanical loss of muscle tissue as a target for insulin-dependent glucose uptake [6,7]. This evidence concerns the gene INS and proximal spinal muscular atrophy.